Pulmonx Corporation
LUNG • NASDAQ
Pulmonx Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Glendon E. French, with a market cap of $49.4M.
CEOGlendon E. French
Next Earnings
Upcoming earnings announcement for Pulmonx Corporation
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.33
Revenue Estimate
$20.3M
Earnings History
Past 12 earnings reports for Pulmonx Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.25Est: -$0.39 | +35.9% | $22.6MEst: $21.7M | +4.0% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.34Est: -$0.41 | +17.1% | $21.5MEst: $20.8M | +3.4% | 10-Q |
| Jul 30, 2025 | Q2 2025 | -$0.38Est: -$0.40 | +5.0% | $23.9MEst: $23.5M | +1.5% | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.36Est: -$0.40 | +10.0% | $22.5MEst: $22.0M | +2.3% | 10-Q |
| Feb 19, 2025 | Q4 2024 | -$0.33Est: -$0.45 | +26.7% | $23.8MEst: $22.3M | +6.6% | 10-K |
| Oct 30, 2024 | Q3 2024 | -$0.36Est: -$0.45 | +20.0% | $20.4MEst: $20.3M | +0.5% | 10-Q |
| Jul 31, 2024 | Q2 2024 | -$0.39Est: -$0.42 | +7.1% | $20.8MEst: $20.1M | +3.2% | 10-Q |
| May 1, 2024 | Q1 2024 | -$0.36Est: -$0.46 | +21.7% | $18.9MEst: $17.9M | +5.4% | 10-Q |
| Feb 21, 2024 | Q4 2023 | -$0.36Est: -$0.41 | +12.2% | $19.3MEst: $18.3M | +5.5% | 10-K |
| Oct 30, 2023 | Q3 2023 | -$0.39Est: -$0.43 | +9.3% | $17.7MEst: $16.4M | +7.8% | — |
| Aug 2, 2023 | Q2 2023 | -$0.43Est: -$0.43 | 0.0% | $17.2MEst: $15.9M | +8.1% | 10-Q |
| May 2, 2023 | Q1 2023 | -$0.42Est: -$0.44 | +4.5% | $14.5MEst: $13.5M | +7.7% | — |